Ark Invest made major portfolio shifts on Tuesday April 22, 2025, boosting stakes in Nvidia, AMD, and Airbnb while trimming Microsoft and others to reposition amid U.S. chip export restrictions and ...

BofA analyst Michael Ryskin lowered the firm’s price target on 10x Genomics (TXG) to $12 from $16 and keeps a Neutral rating on the shares.

TXG opened at $8.01 on Thursday. The stock has a market capitalization of $979.64 million, a P/E ratio of -5.27 and a beta of 2.01. 10x Genomics has a 12-month low of $6.78 and a 12-month high of ...

Calling Indian private healthcare "10x better," she praised its speed and efficiency despite common criticism. Tech Professional in Amsterdam Returns to India for Doctor Visits, Cites Better ...

In a report released today, Luke Sergott from Barclays maintained a Buy rating on 10x Genomics (TXG – Research Report), with a price target of $12.00. The company’s shares closed yesterday at $8.67.

who was recently recognized with the National Academy of Sciences Prize in Food and Agriculture Sciences for his contributions to poultry genomics. The project is part of the international ...

What Happened? A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump announced a 90-day tariff pause. Reciprocal tariffs were also dropped to 10 ...

Millennium Management's Israel Englander purchased 4.54 million shares of 10X Genomics (NASDAQ:TXG) to own a total of 5.53 million shares, according to a 4th April filing. The hedge fund's stake ...